M
Maureen E. Trudeau
Researcher at Sunnybrook Health Sciences Centre
Publications - 259
Citations - 14303
Maureen E. Trudeau is an academic researcher from Sunnybrook Health Sciences Centre. The author has contributed to research in topics: Breast cancer & Cancer. The author has an hindex of 51, co-authored 235 publications receiving 12424 citations. Previous affiliations of Maureen E. Trudeau include York University & Women's College Hospital.
Papers
More filters
Journal ArticleDOI
Abstract P4-12-11: Eq-5d-5l utility scores for patients with breast cancer
Sofia Torres,Ahmed M. Bayoumi,Maureen E. Trudeau,Ana Beatriz Kinupe Abrahao,Nicholas Mitsakakis,Murray Krahn,Geoff Liu +6 more
TL;DR: EQ-5D-5L health utilities were significantly lower for metastatic BC, but no significant differences were found among various early-stage BC states, and BC had an impact mainly in the “Pain/Discomfort” and “Anxiety/Depression” dimensions of EQ- 5D.
Journal ArticleDOI
Home care utilization and costs in stage IV lung cancer: a Canadian public payer experience
Nicole Mittmann,Nicole Mittmann,Soo Jin Seung,Ning Liu,Joan Porter,Natasha B. Leighl,Natasha B. Leighl,Maureen E. Trudeau,Maureen E. Trudeau,William K. Evans,Craig C. Earle,Craig C. Earle +11 more
TL;DR: HCS costs for stage IV patients are less expensive than other health resources and comparing HCS utilization and costs by phase of disease.
Risk o f M enopause D uring t he F irst Y ear A fter B reast Cancer D iagnosis
TL;DR: Age and systemic chemotherapy are the strongest predictors of menopause in women with locoregional breast cancer, and it may facilitate clinical decision-making.
Journal ArticleDOI
Abstract P6-05-43: Validity of EQ-5D-5L for women with breast cancer
TL;DR: Torres et al. as discussed by the authors investigated the construct validity of EuroQol-5 Dimension (EQ-5D) in women with breast cancer, which is a generic patient-reported outcome measure widely used to capture meaningful change in health-related quality of life between treatments to inform drug and health technology reimbursement decision making.
Journal ArticleDOI
Vers une approche multidisciplinaire optimale du traitement du cancer du sein chez les patientes plus âgées
Nemica Thavarajah,Ines B. Menjak,Maureen E. Trudeau,Rajin Mehta,Frances Wright,Angela Leahey,Janet Ellis,Damian Gallagher,Jennifer Moore,Bonnie Bristow,Noreen Kay,Ewa Szumacher +11 more
TL;DR: Nous recommandons un programme interdisciplinaire specifique au traitement des patientes plus âgees atteintes d’un cancer du sein pour l’optimisation of leurs soins de sante.